Lynx1 Capital Management’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.2M | Hold |
7,098,133
| – | – | 2.93% | 8 |
|
|
2025
Q1 | $11.4M | Buy |
7,098,133
+245,389
| +4% | +$393K | 4.07% | 7 |
|
|
2024
Q4 | $24.7M | Sell |
6,852,744
-27,783
| -0.4% | -$100K | 9.25% | 4 |
|
|
2024
Q3 | $39.2M | Hold |
6,880,527
| – | – | 13.9% | 3 |
|
|
2024
Q2 | $31.8M | Buy |
6,880,527
+3,245,865
| +89% | +$15M | 11.47% | 4 |
|
|
2024
Q1 | $29.7M | Buy |
3,634,662
+500,266
| +16% | +$4.09M | 7.65% | 7 |
|
|
2023
Q4 | $17.7M | Buy |
3,134,396
+2,115,166
| +208% | +$12M | 6.96% | 5 |
|
|
2023
Q3 | $1.9M | Buy |
+1,019,230
| New | +$1.9M | 1.25% | 13 |
|